Innov865 Week Ends with a Virtual Celebration of Trailblazing Entrepreneurs and Life-changing Impact KNOXVILLE, Tenn. — The startup 490 BioTech, which developed bioluminescent human cells to show changes in cellular health, won the Innov865 Judges’ Choice Award at Startup Day 2020 with a pitch that explained how its technology can improve development of pharmaceuticals. “Healthy (read more)
Multi Campus Office
UTRF Inventor Spotlight: Dr. Jonathan Wall
A “team effort” for discovering how to diagnose and treat amyloidosis, a rare protein-folding disorder. Amyloidosis is a rare disorder that occurs when an abnormal amyloid protein deposits in organs and tissues, interfering with their ability to function normally. There are approximately 30 different types of amyloidosis, and the disease can either be systemic or (read more)
From Discovery to Biopharmaceutical Startup: UTGSM Innovators Demonstrate Progress in Therapeutics for Systemic Amyloidosis
A team of researchers from the University of Tennessee Graduate School of Medicine has spent more than two decades investigating systemic amyloidosis, a rare and often fatal disorder with few treatments. Their work played an integral role in moving discoveries out of the lab and into clinical trials, helping launch a biopharmaceutical company focused on (read more)